Chhatwal J - Search Results

1

Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness.

Jahn B, Kurzthaler C, Chhatwal J, Elbasha EH, Conrads-Frank A, Rochau U, Sroczynski G, Urach C, Bundo M, Popper N, Siebert U. Jahn B, et al. Among authors: chhatwal j. Med Decis Making. 2019 Jul;39(5):509-522. doi: 10.1177/0272989X19851095. Epub 2019 Jun 28. Med Decis Making. 2019. PMID: 31253053

2

Cost-effectiveness analysis of boceprevir for the treatment of chronic hepatitis C virus genotype 1 infection in Portugal.

Elbasha EH, Chhatwal J, Ferrante SA, El Khoury AC, Laires PA. Elbasha EH, et al. Among authors: chhatwal j. Appl Health Econ Health Policy. 2013 Feb;11(1):65-78. doi: 10.1007/s40258-012-0007-8. Appl Health Econ Health Policy. 2013. PMID: 23355388

3

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.

Ferrante SA, Chhatwal J, Brass CA, El Khoury AC, Poordad F, Bronowicki JP, Elbasha EH. Ferrante SA, et al. Among authors: chhatwal j. BMC Infect Dis. 2013 Apr 27;13:190. doi: 10.1186/1471-2334-13-190. BMC Infect Dis. 2013. PMID: 23621902 Free PMC article. Clinical Trial.

4

Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.

Chhatwal J, Ferrante SA, Brass C, El Khoury AC, Burroughs M, Bacon B, Esteban-Mur R, Elbasha EH. Chhatwal J, et al. Value Health. 2013 Sep-Oct;16(6):973-86. doi: 10.1016/j.jval.2013.07.006. Value Health. 2013. PMID: 24041347 Free PMC article.

5

Characterizing Heterogeneity Bias in Cohort-Based Models.

Elbasha EH, Chhatwal J. Elbasha EH, et al. Among authors: chhatwal j. Pharmacoeconomics. 2015 Aug;33(8):857-65. doi: 10.1007/s40273-015-0273-z. Pharmacoeconomics. 2015. PMID: 25851486

6

Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods.

Elbasha EH, Chhatwal J. Elbasha EH, et al. Among authors: chhatwal j. Med Decis Making. 2016 Jan;36(1):115-31. doi: 10.1177/0272989X15585121. Epub 2015 Jun 19. Med Decis Making. 2016. PMID: 26092831

7

Myths and Misconceptions of Within-Cycle Correction: A Guide for Modelers and Decision Makers.

Elbasha EH, Chhatwal J. Elbasha EH, et al. Among authors: chhatwal j. Pharmacoeconomics. 2016 Jan;34(1):13-22. doi: 10.1007/s40273-015-0337-0. Pharmacoeconomics. 2016. PMID: 26643402

8

Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals.

Chhatwal J, He T, Lopez-Olivo MA. Chhatwal J, et al. Pharmacoeconomics. 2016 Jun;34(6):551-67. doi: 10.1007/s40273-015-0373-9. Pharmacoeconomics. 2016. PMID: 26748919 Review.

9

Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.

Chhatwal J, Jayasuriya S, Elbasha EH. Chhatwal J, et al. Med Decis Making. 2016 Nov;36(8):952-64. doi: 10.1177/0272989X16656165. Epub 2016 Jul 1. Med Decis Making. 2016. PMID: 27369084 Free PMC article.

10

Sensitivity Analysis in Sequential Decision Models.

Chen Q, Ayer T, Chhatwal J. Chen Q, et al. Among authors: chhatwal j. Med Decis Making. 2017 Feb;37(2):243-252. doi: 10.1177/0272989X16670605. Epub 2016 Sep 29. Med Decis Making. 2017. PMID: 27681992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page